Strides Pharma Science informs about press release

20 Jan 2025 Evaluate

Strides Pharma Science has informed that it enclosed Press Release issued by the Company titled: ‘Strides receives USFDA approval for Acetaminophen and Ibuprofen Tablets, 125 mg /250 mg, Expanding the Existing OTC Portfolio’.

The above information is a part of company’s filings submitted to BSE.


Strides Pharma Scien Share Price

893.00 -17.45 (-1.92%)
29-Dec-2025 15:24 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.70
Dr. Reddys Lab 1268.45
Cipla 1493.20
Zydus Lifesciences 904.00
Lupin 2079.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×